Rankings
▼
Calendar
VCEL Q3 2021 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
+7.0% YoY
Gross Profit
$22M
64.0% margin
Operating Income
-$5M
-14.4% margin
Net Income
-$5M
-14.3% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
-12.7%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$1M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$224M
Total Liabilities
$67M
Stockholders' Equity
$157M
Cash & Equivalents
$55M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$32M
+7.0%
Gross Profit
$22M
$22M
-1.7%
Operating Income
-$5M
$4M
-241.1%
Net Income
-$5M
$4M
-236.3%
Revenue Segments
MACI Implants and Kits, and Epicel
$34M
100%
← FY 2021
All Quarters
Q4 2021 →